Catawba Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-10,027
| Closed | -$333K | – | 229 |
|
|
2017
Q2 | $333K | Sell |
10,027
-890
| -8% | -$29.6K | 0.08% | 174 |
|
|
2017
Q1 | $350K | Sell |
10,917
-10,367
| -49% | -$332K | 0.08% | 188 |
|
|
2016
Q4 | $772K | Sell |
21,284
-7,370
| -26% | -$267K | 0.18% | 119 |
|
|
2016
Q3 | $1.32M | Hold |
28,654
| – | – | 0.31% | 82 |
|
|
2016
Q2 | $1.44M | Buy |
28,654
+100
| +0.4% | +$5.02K | 0.35% | 78 |
|
|
2016
Q1 | $1.53M | Hold |
28,554
| – | – | 0.39% | 73 |
|
|
2015
Q4 | $1.87M | Sell |
28,554
-10
| -0% | -$656 | 0.51% | 62 |
|
|
2015
Q3 | $1.61M | Sell |
28,564
-1,000
| -3% | -$56.5K | 0.44% | 69 |
|
|
2015
Q2 | $1.75M | Hold |
29,564
| – | – | 0.42% | 73 |
|
|
2015
Q1 | $1.84M | Hold |
29,564
| – | – | 0.42% | 71 |
|
|
2014
Q4 | $1.7M | Hold |
29,564
| – | – | 0.39% | 76 |
|
|
2014
Q3 | $1.59M | Hold |
29,564
| – | – | 0.37% | 78 |
|
|
2014
Q2 | $1.55M | Sell |
29,564
-175
| -0.6% | -$9.18K | 0.35% | 79 |
|
|
2014
Q1 | $1.57M | Sell |
29,739
-3,355
| -10% | -$177K | 0.37% | 76 |
|
|
2013
Q4 | $1.33M | Sell |
33,094
-17,909
| -35% | -$718K | 0.32% | 82 |
|
|
2013
Q3 | $1.93M | Sell |
51,003
-675
| -1% | -$25.5K | 0.5% | 70 |
|
|
2013
Q2 | $2.03M | Buy |
+51,678
| New | +$2.03M | 0.56% | 64 |
|